Abstract
In this research, we have reported the synthesis of Methyl-4-(4-chlorophenyl)-5-cyano-2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate which is a hybrid of two different biologically active structures. The obtained product was characterized by FT-IR, 1HNMR, 13C NMR, SCXRD and HR-MS. The obtained compound was recrystallized in ethanol giving colourless pure single crystals. SCXRD analysis showed two symmetry independent asymmetric molecules with interesting structural features. Multiple graph sets were also observed which supported the formation of a supramolecular network. DFT studies using B3LYP and M06–2X functions revealed two stable conformers which is in support of the crystal structures obtained. Furthermore, in silico molecular docking analysis in Eg5 kinesin and survivin protein revealed binding affinities of -6.9 kcal/mol and -6.1 kcal/mol respectively. All the results obtained suggests the need of further exploration to discover the complete pharmaceutical potential.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.